应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PULM Pulmatrix, Inc.
未开盘 11-18 16:00:00 EST
6.72
+0.16
+2.44%
盘后
6.70
-0.02
-0.30%
19:59 EST
最高
8.44
最低
6.66
成交量
144.13万
今开
7.10
昨收
6.56
日振幅
27.13%
总市值
2,454万
流通市值
2,454万
总股本
365.23万
成交额
1,101万
换手率
39.46%
流通股本
365.23万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Pulmatrix, Inc.盘中异动 早盘快速拉升14.02%报7.48美元
市场透视 · 11-18 22:31
Pulmatrix, Inc.盘中异动 早盘快速拉升14.02%报7.48美元
Pulmatrix, Inc.2024财年第三财季实现净利润-2.59百万美元,同比增加31.30%
市场透视 · 11-16
Pulmatrix, Inc.2024财年第三财季实现净利润-2.59百万美元,同比增加31.30%
Pulmatrix, Inc.盘中异动 早盘急速上涨10.64%
市场透视 · 11-15
Pulmatrix, Inc.盘中异动 早盘急速上涨10.64%
Os Therapies Incorporated盘中异动 大幅跳水5.95%
市场透视 · 11-15
Os Therapies Incorporated盘中异动 大幅跳水5.95%
艾吉纳斯盘中异动 股价大跌5.12%
市场透视 · 11-15
艾吉纳斯盘中异动 股价大跌5.12%
Tnf Pharmaceuticals, Inc.盘中异动 大幅跳水7.19%
市场透视 · 11-15
Tnf Pharmaceuticals, Inc.盘中异动 大幅跳水7.19%
Orchestra Biomed Holdings, Inc.盘中异动 大幅拉升7.08%
市场透视 · 11-15
Orchestra Biomed Holdings, Inc.盘中异动 大幅拉升7.08%
Evaxion Biotech As盘中异动 临近午盘快速上涨6.64%
市场透视 · 11-15
Evaxion Biotech As盘中异动 临近午盘快速上涨6.64%
Io Biotech, Inc.盘中异动 临近午盘股价大跌5.16%报0.920美元
市场透视 · 11-15
Io Biotech, Inc.盘中异动 临近午盘股价大跌5.16%报0.920美元
Palisade Bio, Inc.盘中异动 大幅上涨6.80%报2.35美元
市场透视 · 11-15
Palisade Bio, Inc.盘中异动 大幅上涨6.80%报2.35美元
Renovaro Inc.盘中异动 股价大涨5.70%
市场透视 · 11-14
Renovaro Inc.盘中异动 股价大涨5.70%
Verrica制药盘中异动 早盘快速上涨5.26%
市场透视 · 11-14
Verrica制药盘中异动 早盘快速上涨5.26%
Biomx Inc.盘中异动 股价大涨8.45%
市场透视 · 11-14
Biomx Inc.盘中异动 股价大涨8.45%
Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.60%
市场透视 · 11-14
Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.60%
Vincerx Pharma, Inc.盘中异动 急速跳水5.19%报0.307美元
市场透视 · 11-14
Vincerx Pharma, Inc.盘中异动 急速跳水5.19%报0.307美元
Prokidney Corp.盘中异动 早盘股价大涨5.07%
市场透视 · 11-14
Prokidney Corp.盘中异动 早盘股价大涨5.07%
Oric Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报9.76美元
市场透视 · 11-14
Oric Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报9.76美元
万春医药盘中异动 早盘快速拉升5.95%报1.96美元
市场透视 · 11-14
万春医药盘中异动 早盘快速拉升5.95%报1.96美元
Vaccinex, Inc.盘中异动 早盘股价大涨7.54%报3.71美元
市场透视 · 11-14
Vaccinex, Inc.盘中异动 早盘股价大涨7.54%报3.71美元
Chimerix, Inc.盘中异动 股价大跌5.26%
市场透视 · 11-14
Chimerix, Inc.盘中异动 股价大跌5.26%
公司概况
公司名称:
Pulmatrix, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Pulmatrix, Inc.,于2013年1月18日注册在内华达州, 作为Oculus Innovative Sciences公司的全资子公司。该公司是一家生物制药公司,致力于次氯酸、侵入性疗法(旨在预防和治疗侵入性感染)的发现、发展和商业化。Pulmatrix领先的候选药物RUT58-60,是一种广谱抗感染药,其开发应用于预防和治疗手术和创伤过程中的感染。
发行价格:
--
{"stockData":{"symbol":"PULM","market":"US","secType":"STK","nameCN":"Pulmatrix, Inc.","latestPrice":6.72,"timestamp":1731963600000,"preClose":6.56,"halted":0,"volume":1441343,"hourTrading":{"tag":"盘后","latestPrice":6.7,"preClose":6.72,"latestTime":"19:59 EST","volume":12303,"amount":84314.0407,"timestamp":1731977968107},"delay":0,"floatShares":3652260,"shares":3652285,"eps":-2.643823,"marketStatus":"未开盘","marketStatusCode":0,"change":0.16,"latestTime":"11-18 16:00:00 EST","open":7.1,"high":8.4399,"low":6.66,"amount":11011691.3063318,"amplitude":0.271326,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.643823,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1395374400000,"adjPreClose":6.56,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.93,"preClose":6.56,"latestTime":"09:29 EST","volume":23234,"amount":155178.02727999998,"timestamp":1731940199999},"postHourTrading":{"tag":"盘后","latestPrice":6.7,"preClose":6.72,"latestTime":"19:59 EST","volume":12303,"amount":84314.0407,"timestamp":1731977968107},"volumeRatio":0.301491},"requestUrl":"/m/hq/s/PULM/wiki","defaultTab":"wiki","newsList":[{"id":"2484675439","title":"Pulmatrix, Inc.盘中异动 早盘快速拉升14.02%报7.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484675439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484675439?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940305,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分,Pulmatrix, Inc.股票出现异动,股价急速拉升14.02%。截至发稿,该股报7.48美元/股,成交量10.9961万股,换手率3.01%,振幅7.47%。Pulmatrix, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。Pulmatrix, Inc.公司简介:Pulmatrix Inc是一家临床阶段的生物技术公司。Pulmatrix基于其专有的干粉输送技术iSPERSE设计和开发了吸入治疗产品,该技术可通过局部或全身应用将小分子或大分子药物吸入肺中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822314595be483a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822314595be483a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PULM"],"gpt_icon":0},{"id":"2483094353","title":"Pulmatrix, Inc.2024财年第三财季实现净利润-2.59百万美元,同比增加31.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483094353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483094353?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日,Pulmatrix, Inc.公布财报,公告显示公司2024财年第三财季净利润为-2.59百万美元,同比增加31.30%;其中营业收入为366000.00美元,同比减少79.09%,每股基本收益为-0.71美元。从资产负债表来看,Pulmatrix, Inc.总负债590000.00美元,其中短期债务0.00美元,资产负债比为0.01,流动比率为0.01。机构评级:截至2024年11月16日,当前有1家机构对Pulmatrix, Inc.目标价做出预测,其中目标均价为10.00美元,其中最低目标价为10.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000317a23b89d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000317a23b89d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM"],"gpt_icon":0},{"id":"2483372978","title":"Pulmatrix, Inc.盘中异动 早盘急速上涨10.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372978?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:33","pubTimestamp":1731681192,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时33分,Pulmatrix, Inc.股票出现异动,股价大幅上涨10.64%。Pulmatrix, Inc.股票所在的生物技术行业中,整体跌幅为1.31%。Pulmatrix, Inc.公司简介:Pulmatrix Inc是一家临床阶段的生物技术公司。消息层面,截至22时33分,《Pulmatrix和Cullgen宣布拟合并》资讯为影响Pulmatrix, Inc.的重要信息。根据合并协议,Pulmatrix计划剥离其资产,包括其急性偏头痛候选药物PUR3100和其他基于其iSPERSE技术的开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223313abc4e7b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223313abc4e7b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PULM"],"gpt_icon":0},{"id":"2483033382","title":"Os Therapies Incorporated盘中异动 大幅跳水5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483033382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483033382?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:33","pubTimestamp":1731605596,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时33分,Os Therapies Incorporated股票出现波动,股价大幅跳水5.95%。Os Therapies Incorporated股票所在的生物技术行业中,整体跌幅为0.84%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、奥麦罗制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3655.19%、3217.86%、365.39%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、106.82%。Os Therapies Incorporated公司简介:OS Therapies Inc 是一家临床阶段的生物制药公司,专注于骨肉瘤和其他实体瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013316a2383b03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013316a2383b03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","PULM","BK4007","BK4139"],"gpt_icon":0},{"id":"2483382449","title":"艾吉纳斯盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483382449?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:25","pubTimestamp":1731605106,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时25分,艾吉纳斯股票出现异动,股价快速跳水5.12%。截至发稿,该股报2.88美元/股,成交量47.6673万股,换手率2.21%,振幅7.26%。艾吉纳斯股票所在的生物技术行业中,整体跌幅为0.72%。其相关个股中,Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、X4制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3564.87%、3199.09%、362.99%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、86.36%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012507abc1bfaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012507abc1bfaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","AGEN","BK4139","BK4007"],"gpt_icon":0},{"id":"2483384066","title":"Tnf Pharmaceuticals, Inc.盘中异动 大幅跳水7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384066?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:22","pubTimestamp":1731604930,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时22分,Tnf Pharmaceuticals, Inc.股票出现波动,股价大幅跳水7.19%。Tnf Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.67%。其相关个股中,Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3526.71%、3195.01%、362.13%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、86.36%。Tnf Pharmaceuticals, Inc.公司简介:TNF Pharmaceuticals Inc是一家临床阶段的制药公司,致力于延长健康的寿命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012210971a69d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012210971a69d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBD","BK4007","PULM","TNFA","BK4113"],"gpt_icon":0},{"id":"2483381258","title":"Orchestra Biomed Holdings, Inc.盘中异动 大幅拉升7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483381258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483381258?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:02","pubTimestamp":1731603743,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时02分,Orchestra Biomed Holdings, Inc.股票出现波动,股价快速拉升7.08%。Orchestra Biomed Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3173.01%、3100.32%、354.39%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、86.36%。Orchestra Biomed Holdings, Inc.公司简介:Orchestra BioMed Holdings Inc 是一家生物医学创新公司,通过风险回报共享合作伙伴关系加速为患者提供高影响力技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115010223a2382d86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115010223a2382d86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4082","OBIO","PULM"],"gpt_icon":0},{"id":"2483381486","title":"Evaxion Biotech As盘中异动 临近午盘快速上涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483381486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483381486?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:49","pubTimestamp":1731602988,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时49分,Evaxion Biotech As股票出现异动,股价急速拉升6.64%。截至发稿,该股报1.88美元/股,成交量3.0958万股,换手率0.55%,振幅4.55%。Evaxion Biotech As股票所在的生物技术行业中,整体跌幅为0.59%。Evaxion Biotech As公司简介:Evaxion Biotech AS 是一家临床阶段的生物技术公司,致力于探索人工智能或 AI,开发与目前上市产品相比疗效更好的免疫疗法,以满足未满足医疗需求的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115004949971a69c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115004949971a69c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVAX","BK4007","PULM"],"gpt_icon":0},{"id":"2483389184","title":"Io Biotech, Inc.盘中异动 临近午盘股价大跌5.16%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483389184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483389184?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:45","pubTimestamp":1731602728,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时45分,Io Biotech, Inc.股票出现波动,股价大幅跳水5.16%。截至发稿,该股报0.920美元/股,成交量5.2593万股,换手率0.08%,振幅7.63%。Io Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Io Biotech, Inc.公司简介:IO Biotech Inc 是一家临床阶段的生物制药公司,开发基于 T-win 技术平台的新型免疫调节癌症疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115004528971a69c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115004528971a69c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOBT","PULM","BK4007"],"gpt_icon":0},{"id":"2483389193","title":"Palisade Bio, Inc.盘中异动 大幅上涨6.80%报2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483389193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483389193?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:21","pubTimestamp":1731601297,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时21分,Palisade Bio, Inc.股票出现异动,股价大幅拉升6.80%。截至发稿,该股报2.35美元/股,成交量2.1029万股,换手率1.37%,振幅4.35%。Palisade Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。Palisade Bio, Inc.公司简介:Palisade Bio Inc 是一家临床阶段的生物制药公司,专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115002137971a69ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115002137971a69ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PULM","BK4007","PALI"],"gpt_icon":0},{"id":"2483385684","title":"Renovaro Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385684?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:54","pubTimestamp":1731599640,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时54分,Renovaro Inc.股票出现波动,股价快速上涨5.70%。截至发稿,该股报0.636美元/股,成交量3.7855万股,换手率0.02%,振幅4.65%。Renovaro Inc.股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大,Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2766.57%、260.85%、40.66%,振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药,振幅分别为112.92%、86.36%、73.75%。Renovaro Inc.公司简介:Renovaro Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235401abc18558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235401abc18558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","BK4007","PULM","BK4139"],"gpt_icon":0},{"id":"2483385675","title":"Verrica制药盘中异动 早盘快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385675?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:53","pubTimestamp":1731599603,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时53分,Verrica制药股票出现异动,股价快速拉升5.26%。截至发稿,该股报0.890美元/股,成交量8.9049万股,换手率0.20%,振幅6.52%。Verrica制药股票所在的生物技术行业中,整体跌幅为0.46%。Verrica制药公司简介:Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司,致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235323a237fc85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235323a237fc85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","VRCA","BK4007"],"gpt_icon":0},{"id":"2483385509","title":"Biomx Inc.盘中异动 股价大涨8.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385509?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:52","pubTimestamp":1731599575,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时52分,Biomx Inc.股票出现异动,股价快速上涨8.45%。截至发稿,该股报0.785美元/股,成交量2.2431万股,换手率0.13%,振幅3.73%。Biomx Inc.股票所在的生物技术行业中,整体跌幅为0.42%。Biomx Inc.公司简介:BiomX Inc是一家位于以色列的临床阶段微生物组公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111423525598e42afe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111423525598e42afe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","PHGE","BK4007","BK4139"],"gpt_icon":0},{"id":"2483738553","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738553?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:52","pubTimestamp":1731599559,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时52分,Nrx Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.60%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。Nrx Pharmaceuticals, Inc.公司简介:NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司,开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235239a237fc1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235239a237fc1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007","PULM"],"gpt_icon":0},{"id":"2483388748","title":"Vincerx Pharma, Inc.盘中异动 急速跳水5.19%报0.307美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388748?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:47","pubTimestamp":1731599247,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时47分,Vincerx Pharma, Inc.股票出现波动,股价急速下挫5.19%。Vincerx Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。Vincerx Pharma, Inc.公司简介:Vincerx Pharma Inc 是一家临床阶段生物制药公司,专注于开发和肿瘤学方面的专业知识,以推进新疗法的发展,满足治疗癌症方面尚未得到满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234727a237f9e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234727a237f9e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VINC","PULM","BK4139"],"gpt_icon":0},{"id":"2483388410","title":"Prokidney Corp.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388410?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:46","pubTimestamp":1731599166,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时46分,Prokidney Corp.股票出现异动,股价急速上涨5.07%。截至发稿,该股报2.18美元/股,成交量8.6379万股,换手率0.07%,振幅7.81%。Prokidney Corp.股票所在的生物技术行业中,整体跌幅为0.46%。Prokidney Corp.公司简介:ProKidney Corp 是一家临床阶段生物技术公司,它拥有一个变革性的专有细胞疗法平台,能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234606abc1822a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234606abc1822a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PULM","BK4139","PROK"],"gpt_icon":0},{"id":"2483495388","title":"Oric Pharmaceuticals, Inc.盘中异动 大幅下挫5.01%报9.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483495388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483495388?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:45","pubTimestamp":1731599140,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时45分,Oric Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.01%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大,Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2707.20%、228.01%、39.85%,振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药,振幅分别为112.92%、86.36%、73.75%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234540971a698f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234540971a698f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4139","ORIC","BK4007"],"gpt_icon":0},{"id":"2483115388","title":"万春医药盘中异动 早盘快速拉升5.95%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483115388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483115388?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:44","pubTimestamp":1731599057,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时44分,万春医药股票出现波动,股价快速上涨5.95%。截至发稿,该股报1.96美元/股,成交量2135股,换手率0.01%,振幅1.08%。万春医药股票所在的生物技术行业中,整体跌幅为0.61%。万春医药公司简介:BeyondSpring Inc 从事临床阶段的生物制药活动,重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111423441798e42aee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111423441798e42aee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PULM","BK4007","BYSI"],"gpt_icon":0},{"id":"2483887453","title":"Vaccinex, Inc.盘中异动 早盘股价大涨7.54%报3.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483887453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483887453?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:39","pubTimestamp":1731598783,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时39分,Vaccinex, Inc.股票出现异动,股价大幅上涨7.54%。截至发稿,该股报3.71美元/股,成交量1.3271万股,换手率0.47%,振幅7.08%。Vaccinex, Inc.股票所在的生物技术行业中,整体跌幅为0.63%。Vaccinex, Inc.公司简介:Vaccinex Inc 正在开创一种通过抑制信号蛋白4D 来治疗癌症和缓慢进展的神经退行性疾病的差异化方法。该公司的主要候选药物pepinemab阻断SEMA4D, SEMA4D是一种强有力的生物效应物,认为可以防止免疫渗入肿瘤并引发慢性脑部疾病的炎症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233943a237f667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233943a237f667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PULM","VCNX","BK4568","BK4007"],"gpt_icon":0},{"id":"2483388112","title":"Chimerix, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388112?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:38","pubTimestamp":1731598732,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时38分,Chimerix, Inc.股票出现波动,股价快速下跌5.26%。Chimerix, Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大,Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2670.85%、196.45%、38.66%,振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药,振幅分别为112.92%、86.36%、73.75%。Chimerix, Inc.公司简介:Chimerix Inc.是一家总部位于美国的生物制药公司,从事药物的研究,开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233852971a698b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233852971a698b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMRX","BK4583","BK4139","BK4007","PULM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pulmatrix.com","stockEarnings":[{"period":"1week","weight":2.2479},{"period":"1month","weight":2.3261},{"period":"3month","weight":2.3267},{"period":"6month","weight":2.3939},{"period":"1year","weight":2.7025},{"period":"ytd","weight":2.6129}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pulmatrix, Inc.,于2013年1月18日注册在内华达州, 作为Oculus Innovative Sciences公司的全资子公司。该公司是一家生物制药公司,致力于次氯酸、侵入性疗法(旨在预防和治疗侵入性感染)的发现、发展和商业化。Pulmatrix领先的候选药物RUT58-60,是一种广谱抗感染药,其开发应用于预防和治疗手术和创伤过程中的感染。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.330536},{"month":2,"riseRate":0.4,"avgChangeRate":0.027977},{"month":3,"riseRate":0.3,"avgChangeRate":-0.132149},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.043665},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.002975},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.044071},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.066495},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.10206},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.034766},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.068651},{"month":11,"riseRate":0.454545,"avgChangeRate":0.171753},{"month":12,"riseRate":0.2,"avgChangeRate":-0.127506}],"exchange":"NASDAQ","name":"Pulmatrix, Inc.","nameEN":"Pulmatrix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulmatrix, Inc.(PULM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pulmatrix, Inc.(PULM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pulmatrix, Inc.,PULM,Pulmatrix, Inc.股票,Pulmatrix, Inc.股票老虎,Pulmatrix, Inc.股票老虎国际,Pulmatrix, Inc.行情,Pulmatrix, Inc.股票行情,Pulmatrix, Inc.股价,Pulmatrix, Inc.股市,Pulmatrix, Inc.股票价格,Pulmatrix, Inc.股票交易,Pulmatrix, Inc.股票购买,Pulmatrix, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulmatrix, Inc.(PULM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pulmatrix, Inc.(PULM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}